Lucid Diagnostics Inc
Statements
Cash Flow
Lucid Diagnostics Inc (LUCD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -11 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 18 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.2 | -1.1 | -1.3 | -1.6 | -1.7 | -3.3 | -2.4 | -2.2 | -9.9 | -5.8 | -13 | -6.3 | -4.3 | -7.0 | -7.0 | -8.8 | -10.0 | -13 | -11 | -10 | -9.9 | -12 | -11 | -11 | -13 | -12 | -11 | -47 | |
| – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 429 | 0.2 | 0.2 | 429 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 2.6 | 2.8 | 3.4 | 3.8 | 3.8 | 3.6 | 3.7 | 3.2 | 1.4 | 1.3 | 1.0 | 0.9 | 1.2 | 1.2 | 1.2 | 1.0 | 1.1 | 1.2 | 2,294 | 1.4 | 1.7 | 2,298 | |
| – | – | – | 0.0 | 0.0 | 0.8 | 2.6 | 2.8 | 3.4 | 4.0 | 3.9 | 3.8 | 4.0 | 2.8 | 1.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 1.1 | 0.0 | 0.5 | 1.0 | -0.5 | 1.1 | 2.0 | -2.0 | 2.6 | -3.5 | 3.7 | 6.1 | 2.7 | 2.7 | 0.5 | -0.2 | -3.3 | -1.9 | -0.1 | 1.0 | -1.4 | -0.7 | -0.7 | 0.0 | -1.7 | -0.5 | -3.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.1 | 0.2 | 0.3 | 0.2 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.4 | 0.3 | 0.1 | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 | 0.3 | |
| – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.8 | -0.1 | -2.4 | -1.3 | -0.2 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | – | -0.4 | -0.3 | -0.1 | 0.0 | 0.0 | -0.1 | -0.2 | 0.0 | -0.3 | |
| – | – | – | – | – | – | – | – | – | – | – | 0.1 | 109 | 276 | – | – | 275 | 353 | – | 94 | – | 141 | 0.0 | 272 | 131 | 210 | 210 | 823 | |
| – | – | – | 1.1 | 1.3 | 3.3 | 4.4 | 0.0 | 0.0 | – | – | 9.9 | 9.9 | 9.9 | 0.1 | – | – | – | – | 0.0 | 18 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.2 | 1.3 | 1.6 | 1.1 | 1.6 | 3.3 | 4.6 | 0.4 | 64 | 0.2 | 0.5 | 1.9 | 0.0 | 24 | 0.1 | 0.3 | 5.0 | 19 | 12 | 0.1 | 18 | 15 | 16 | 27 | 0.0 | 5.5 | 17 | 49 | |
| 0.0 | -0.2 | 0.3 | -0.5 | -0.1 | 0.0 | 2.1 | -2.2 | 54 | -5.7 | -15 | -5.7 | -4.5 | 17 | -7.0 | -8.5 | -5.2 | 5.9 | 0.2 | -10 | 7.9 | 2.9 | 5.9 | 16 | -13 | -6.8 | 5.5 | 2.3 | |
| -0.2 | -1.1 | -1.3 | -1.6 | -1.7 | -3.3 | -2.4 | -2.2 | -11 | -5.9 | -14 | -6.7 | -4.5 | -7.1 | -7.0 | -8.8 | -10 | -13 | -11 | -11 | -10 | -13 | -11 | -11 | -13 | -12 | -11 | -47 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.